Indian COVID-19 vaccine panel chief says Biological E vaccine 90% effective
Foreign
DR N. K. Arora said Biological E’s made-in-India vaccine is expected to have 90 per cent effectiveness against COVID-19 and would likely be a game changer in the fight against the pandemic.
Arora, Head of India’s COVID-19 Working Group of the National Technical Advisory Group on Immunisation (NTAGI), said this on Thursday.
Arora in an interview with a local television news channel NDTV said the vaccine is entering Phase 3 trials and could be available by October.
According to Arora, Biological E’s vaccine to be called Corbevax is similar to the Novavax vaccine.
Biological E will be out likely in October with an efficacy matching Novavax’s.
India started the vaccination against COVID-19 on Jan. 16, by administrating two made in India vaccines namely Covishield and Covaxin.
Recently, Russian COVID-19 vaccine Sputnik V too was rolled out in the country. (Xinhua/NAN)
– June 17, 2021 @ 11:34 GMT |
Related Posts
Koreans, Nigerians celebrate 2024 Nobel Prize laureate, Han Kang
KOREANS and Nigerians in Federal Capital Territory (FCT), on Friday celebrated Korean literary icon, Han Kang, for winning the 2024 Nobel...
Read MoreMorocco accelerates regionalisation process with 4 new agreements
TANGIER (Morocco), Dec. 21, 2024 (NAN) The Kingdom of Morocco’s 12 regions and several ministerial departments, have signed four framework...
Read MoreSouth Korean President Fails To Appear Before Corruption Watchdog
SOUTH Korea’s impeached President Yoon Suk Yeol failed to appear before the country’s corruption watchdog on Wednesday, it said, after...
Read MoreMost Read
Subscribe to Our Newsletter
Keep abreast of news and other developments from our website.